Old Web
English
Sign In
Acemap
>
authorDetail
>
Boulos Haraoui
Boulos Haraoui
Medicine
Rheumatoid arthritis
Physical therapy
Etanercept
Infliximab
4
Papers
86
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry
2017
Annals of the Rheumatic Diseases
Denis Choquette
Louis Bessette
Evo Alemao
Boulos Haraoui
Frédéric Massicotte
M Mtibaa
E Muratti
J.-P. Pelletier
Roelien Postema
J-P Raynauld
M.-A. Rémillard
D. Sauvageau
A Turcotte
Έ. Villeneuve
L. Coupal
Show All
Source
Cite
Save
Citations (0)
Differentiating the efficacy of tumor necrosis factor inhibitors.
2005
The Journal of Rheumatology Supplement
Boulos Haraoui
Show All
Source
Cite
Save
Citations (27)
The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
2005
The Journal of Rheumatology Supplement
Boulos Haraoui
Show All
Source
Cite
Save
Citations (41)
Indomethacin-Induced Inhibition of Prostaglandin with Hyperkalemia
1979
Annals of Internal Medicine
Vincent Beroniade
Louise Corneille
Boulos Haraoui
Show All
Source
Cite
Save
Citations (18)
1